secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aceragen, Inc. (—)
CIK:        0000861838
Form:       8-K
Filed at:   2023-08-16T23:59:59+00:00
Accession:  0001104659-23-092550
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 5.02, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aceragen liquidates via assignment for benefit of creditors; board and CEO resign; delisting
--------------------------------------------------------------------------------

- Stockholders approved assignment for benefit of creditors; company transfers all assets to ACG (ABC), LLC, effective Aug 16.
- Entire Board (Cristina Csimma, Michael Dougherty, Maxine Gowen, Vincent Milano, Ron Wooten) resigns effective Aug 15/16.
- CEO John Taylor terminated; enters separation agreement with $100k success fee for consulting on asset liquidation.
- Company to voluntarily delist from Nasdaq (Form 25 filed Aug 15) and terminate SEC reporting.
- NovaQuest holds first-priority lien; proceeds distributed per Collateral Agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/861838/000110465923092550/0001104659-23-092550-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/861838/000110465923092550/tm2323610d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-092550

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer